Protagonist Therapeutics Inc (PTGX)
EBITDA Growth
582.61%
Quarterly · Period ending:
PTGX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported582.61%period ending
Latest reported582.61%period ending
PTGX Quarterly EBITDA YoY % (-164.80% → 582.61%)
Year-over-year change
High-resolution chart · PNG
PTGX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 582.6097% | |
| 123.5459% | |
| -132.2966% | |
| -18.176% | |
| -15.0221% | |
| -105.4129% | |
| 376.4441% | |
| 0.8865% | |
| 20.7843% | |
| 741.1759% | |
| 188.8661% | |
| -9.5428% | |
| 6.3567% | |
| -63.6712% | |
| 14.3073% | |
| 8.2205% | |
| -33.031% | |
| 14.1044% | |
| -103.2531% | |
| -363.1962% | |
| -73.2653% | |
| -23.1421% | |
| -27.3924% | |
| 54.9773% | |
| 42.2258% | |
| -42.5249% | |
| 6.5362% | |
| -71.8121% | |
| -232.8151% | |
| -63.5505% | |
| -350.0589% | |
| -89.6141% | |
| 39.6928% | |
| 42.5379% | |
| 70.0053% | |
| 30.9426% | |
| -114.6752% | |
| -103.6027% | |
| -130.4029% | |
| -77.6183% | |
| -131.1881% | |
| -164.8043% |